Conning Inc. Regeneron Pharmaceuticals, Inc. Transaction History

Conning Inc.

$2.89 Billion
Q3 2024

A detailed history of Conning Inc. transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Conning Inc. holds 624 shares of REGN stock, worth $460,512. This represents 0.02% of its overall portfolio holdings.

Number of Shares

624

Previous 635 1.73%

Holding current value

$460,512

Previous $667,000 1.8%

% of portfolio

0.02%

Previous 0.03%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$1024.09 - $1201.76 $11,264 - $13,219	-11 Reduced 1.73%	624 $655,000
Q2 2024 Jul 26, 2024	BUY	$883.2 - $1071.19 $14,131 - $17,139	16 Added 2.58%	635 $667,000
Q1 2024 Apr 26, 2024	BUY	$902.69 - $993.35 $42,426 - $46,687	47 Added 8.22%	619 $595,000
Q4 2023 Jan 29, 2024	BUY	$775.18 - $881.7 $1,550 - $1,763	2 Added 0.35%	572 $502,000
Q3 2023 Oct 26, 2023	SELL	$692.45 - $844.37 $6,232 - $7,599	-9 Reduced 1.55%	570 $469,000
Q2 2023 Jul 21, 2023	SELL	$700.03 - $830.35 $49,002 - $58,124	-70 Reduced 10.79%	579 $416,000
Q1 2023 Apr 27, 2023	SELL	$680.49 - $826.97 $4,763 - $5,788	-7 Reduced 1.07%	649 $533,000
Q4 2022 Feb 07, 2023	SELL	$705.89 - $766.39 $2,823 - $3,065	-4 Reduced 0.61%	656 $473,000
Q3 2022 Oct 28, 2022	SELL	$573.97 - $724.32 $19,514 - $24,626	-34 Reduced 4.9%	660 $455,000
Q2 2022 Jul 20, 2022	SELL	$548.35 - $738.84 $2,193 - $2,955	-4 Reduced 0.57%	694 $410,000
Q1 2022 May 02, 2022	SELL	$595.12 - $698.43 $67,843 - $79,621	-114 Reduced 14.04%	698 $487,000
Q4 2021 Jan 27, 2022	SELL	$543.48 - $670.97 $9,239 - $11,406	-17 Reduced 2.05%	812 $513,000
Q3 2021 Nov 05, 2021	SELL	$574.03 - $680.96 $178,523 - $211,778	-311 Reduced 27.28%	829 $502,000
Q2 2021 Jul 29, 2021	SELL	$472.8 - $558.54 $59,100 - $69,817	-125 Reduced 9.88%	1,140 $637,000
Q1 2021 Apr 23, 2021	SELL	$446.73 - $548.2 $45,119 - $55,368	-101 Reduced 7.39%	1,265 $599,000
Q4 2020 Jan 28, 2021	BUY	$478.3 - $607.98 $72,223 - $91,804	151 Added 12.43%	1,366 $660,000
Q3 2020 Oct 21, 2020	BUY	$544.75 - $658.21 $19,066 - $23,037	35 Added 2.97%	1,215 $680,000
Q2 2020 Aug 07, 2020	BUY	$493.32 - $643.92 $64,624 - $84,353	131 Added 12.49%	1,180 $736,000
Q1 2020 Apr 29, 2020	SELL	$336.18 - $494.43 $672 - $988	-2 Reduced 0.19%	1,049 $512,000
Q4 2019 Jan 29, 2020	BUY	$274.13 - $376.51 $21,930 - $30,120	80 Added 8.24%	1,051 $395,000
Q3 2019 Oct 30, 2019	SELL	$273.46 - $318.39 $35,276 - $41,072	-129 Reduced 11.73%	971 $269,000
Q2 2019 Jul 25, 2019	SELL	$299.6 - $414.82 $62,916 - $87,112	-210 Reduced 16.03%	1,100 $344,000
Q1 2019 Apr 22, 2019	SELL	$372.08 - $439.57 $3,720 - $4,395	-10 Reduced 0.76%	1,310 $538,000
Q4 2018 Jan 29, 2019	SELL	$335.82 - $403.04 $134,328 - $161,216	-400 Reduced 23.26%	1,320 $493,000
Q3 2018 Oct 26, 2018	SELL	$351.14 - $408.51 $91,296 - $106,212	-260 Reduced 13.13%	1,720 $695,000
Q2 2018 Jul 25, 2018	SELL	$284.6 - $344.99 $28,460 - $34,499	-100 Reduced 4.81%	1,980 $683,000
Q1 2018 May 04, 2018	SELL	$315.82 - $393.78 $12,632 - $15,751	-40 Reduced 1.89%	2,080 $716,000
Q4 2017 Jan 30, 2018	BUY	$358.63 - $469.95 $3,586 - $4,699	10 Added 0.47%	2,120 $797,000
Q3 2017 Oct 20, 2017	BUY	$431.38 - $504.0 $910,211 - $1.06 Million	2,110	2,110 $943,000

Others Institutions Holding REGN

# of Institutions

1,531

Shares Held

84.1M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.1B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Conning Inc., based on Form 13F filings with the SEC.

News

Stay updated on Conning Inc. with notifications on news.

Account